what is retatrutide peptide used for and its potential benefits. Created in BioRender.com Retatrutide – Retatrutide Peptide: Triple Agonist Mechanism,

Osteocalcin and its endocrine functions

The study also indicated that GLP-1 RA treatment was associated with a moderately increased risk of gallstones (RR: 1.27, 95% CI 1.101.47), cholecystitis (RR: 1.36, 95% CI 1.141.62), and overall gallbladder disease risk (RR: 1.55, 95% CI 1.082.22) compared to placebo

Thats been, like, another big, concerning thing among clinicians cause when you think about weight loss, whether its through a GLP-1 drug, exercise, diet or something like malnutrition, youre losing all different, quote, unquote, types of weight

The trial was preregistered at ClinicalTrials.gov (NCT06309667) on February 14, 2024, and conducted in accordance with the Declaration of Helsinki and the International Council for Harmonisation Good Clinical Practice guidelines